What is GETINGE's annual turnover?
In its 2025 annual report, Getinge reported net sales of SEK 35 billion. Despite facing economic headwinds such as currency fluctuations and tariffs, the company maintained a strong underlying earnings trend, with an adjusted EBITA margin of 14% (which would have been 16% when adjusted for external pressures). The company’s turnover is driven by its diverse portfolio of clinical solutions, including surgical equipment, cardiovascular technology, and life-support systems, which are sold to hospitals and healthcare providers in more than 135 countries worldwide. Getinge's revenue strategy focuses on moving toward higher-margin products and consumables to ensure sustainable long-term growth in the global healthcare technology sector.
Related FAQs
Getinge, a global medical technology company, had a market capitalization of approximately ₹631.66 billion as of July 2026.
Givaudan SA operates with a worldwide workforce comprising approximately nineteen thousand four hundred employees across its global network of production facilities, creation centers, and commercial offices.
Arjo operates as an independent, publicly traded company listed on Nasdaq Stockholm rather than a subsidiary owned by Getinge.
Financial planners and sociological surveys consistently reveal that the single biggest regret among retirees is failing to save enough money early in life and underestimating how quickly compounding investment growth could have secured their future.
Getinge is widely acknowledged as a prominent global medical technology enterprise that provides critical equipment, systems, and software for hospitals, intensive care units, and life science laboratories worldwide.
Getinge AB is a publicly traded Swedish medical technology corporation headquartered in Gothenburg, Sweden, that produces, distributes, and services advanced equipment and systems for global healthcare institutions and life science industries.
Getinge maintains its corporate headquarters roots in the locality of Getinge, Sweden, with its central executive corporate offices situated in Gothenburg, Sweden.
Getinge AB, a major global medical technology multinational enterprise specializing in equipment and systems for intensive care, cardiovascular procedures, and sterile surgical workflows, is headquartered in Getinge, Sweden, while its primary global ...
Yes, Gilead Sciences successfully completed its acquisition of Arcellx, Inc. in April 2026. The transaction was valued at approximately $7.
Getinge, a global medical technology company, provides a comprehensive employee benefits package designed to support workforce health, financial security, and work-life balance.
The average annual salary for a Senior Research and Development or Quality Engineer at Getinge in California is approximately USD 123,653, aligning closely with competitive national benchmarks for the medical device manufacturing sector.